HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
TYRA
Tyra Biosciences Inc
Healthcare Biotechnology · California, USA · Reports in usd
Market Cap: $2.01B
Market Cap
$2.01B
Enterprise Val
$1.76B
P/E Ratio
-16.73
P/B Ratio
7.74
Trailing PEG (1Y)
-0.55
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$259.2M
Return on Equity-41.17%
Return on Assets-38.40%
Current Ratio14.67
Debt/Equity0.02
LT Debt/Equity0.02
Revenue Per Share0.00

Income Statement

Dec 31, 2025
Revenue$0.00
Cost of Revenue$0.00
Gross Profit$0.00
R&D$28.2M
SG&A$8.3M
Operating Expenses$36.5M
Operating Income-$36.5M
Interest Expense$0.00
Tax Expense$0.00
Net Income-$33.8M
EPS (Basic)$-0.56
EPS (Diluted)$-0.56
EBIT-$33.8M
EBITDA-$33.7M
Consolidated Income-$33.8M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$78.4M
Accounts Receivable$0.00
Inventory$0.00
Current Assets$265.5M
LT Investments$0.00
Property, Plant & Equipment$6.9M
Intangibles$0.00
Non-Current Assets$17.2M
Total Assets$282.6M
Accounts Payable$1.2M
Current Debt$472.0K
Current Liabilities$18.1M
LT Debt$5.3M
Non-Current Liabilities$5.3M
Total Liabilities$23.4M
Total Debt$5.8M
Retained Earnings-$371.3M
Shareholder Equity$259.2M
Shares Outstanding53,372,098

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow-$23.6M
Investing Cash Flow$34.4M
Financing Cash Flow$4.7M
CapEx-$57.0K
Free Cash Flow-$23.7M
Depreciation & Amort.$132.0K
Stock-Based Comp$7.6M
Acquisitions / Disposals$0.00
Investment Activity$34.4M
Debt Issued/Repaid$0.00
Equity Issued/Repaid$4.7M
Dividends Paid$0.00
Net Change in Cash$15.4M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h